CommercialCoverageMedium impact
05.00.75a, Percutaneous Electrical Nerve Stimulation (PENS) and Percutaneous Neuromodulation Therapy (PNT)
Independence Blue Cross·Pain Management, Physical Therapy, PM&R (Physical Medicine & Rehab) +1 more·Medical Policy
Effective date
May 28, 2025
We identified it
Jun 19, 2026
Summary
Policy 05.00.75a regarding Percutaneous Electrical Nerve Stimulation (PENS) and Percutaneous Neuromodulation Therapy (PNT) has been reissued effective 05/28/2025. Without access to the full policy content details, the billing team must obtain and review the complete policy document to identify specific coverage criteria, billing code requirements, prior authorization mandates, and any changes from the previous version.
Action Required
By 05/28/2025: Billing team must access the full policy text at https://medpolicy.ibx.com/ibc/Commercial/Pages/Site-Activity-View.aspx?FilterField1=MPSiteActivityLogMonth&FilterValue1=05&FilterField2=MPSiteActivityLogYear&FilterValue2=2025#commercial-05-00-75a and extract specific billing codes (CPT/HCPCS), coverage criteria, and prior authorization requirements for PENS and PNT procedures. Update billing software, encounter forms, and provider documentation templates accordingly. Verify whether this reissue supersedes any previous version of policy 05.00.75a and discontinue use of outdated guidance. Train billing and clinical staff on new requirements before the effective date to prevent claim denials.